Question

In: Finance

You are evaluating to make an investment in a small biotech start-up which will require an...

You are evaluating to make an investment in a small biotech start-up which will require an investment of $2.1 million. The start-up is expecting to generate free cash flows of $200,000 during the first year.

After one year, the insurance companies will decide if the start-up’s drug will be cover in their plans or not. If they decide to not cover the drug, the company will be able to generate free cash flows of $400,000 during the next 12 years (the period of the patent) and zero after that. If the insurance companies decide to cover the drug, the start-up will be able to generate free cash flows of $800,000 during the next 12 years (the period of the patent) and zero after that.

Furthermore, the start-up can also decide to sell the patent to a larger biotech company for $2.5 million after knowing the answer of the insurance companies (end of year 1), whether they cover it or not. You expect that the insurance companies will approve the drug with a 70% probability and you require a 20% return.

What is the NPV of the investment?”

Select one:

a. $796634

b. $582223

c. $763301

d. $1302628

e. $418029

Solutions

Expert Solution

There is common cash flow for both options whether its approved or not in initial investment
and first year that is
Year Cash flow x DF at 20% = Present value
0 $       (2,100,000) 1 $ (2,100,000.00)
1 200000 0.833333333            166,666.67
$ (1,933,333.33)
And after first year, there is some probabilty of approval 70%, and no approval 30%
So suppose there is approval
Year Cash flow x DF at 20% = Present value
2 800000 0.694444444 555555.5556
3 800000 0.578703704 462962.963
4 800000 0.482253086 385802.4691
5 800000 0.401877572 321502.0576
6 800000 0.334897977 267918.3813
7 800000 0.279081647 223265.3178
8 800000 0.232568039 186054.4315
9 800000 0.193806699 155045.3596
10 800000 0.161505583 129204.4663
11 800000 0.134587986 107670.3886
12 800000 0.112156655 89725.32383
13 800000 0.093463879 74771.10319
$    2,959,477.82 x 70% probability
Present value = $    2,071,634.47
Ans , there is n approval
Here again there is two options with company, sell at end of first year
or continue with lower cash flow for 12 years , and options with higher present value will be continued
Year Cash flow x DF at 20% = Present value
2 400000 0.694444444 277777.7778
3 400000 0.578703704 231481.4815
4 400000 0.482253086 192901.2346
5 400000 0.401877572 160751.0288
6 400000 0.334897977 133959.1907
7 400000 0.279081647 111632.6589
8 400000 0.232568039 93027.21574
9 400000 0.193806699 77522.67979
10 400000 0.161505583 64602.23316
11 400000 0.134587986 53835.1943
12 400000 0.112156655 44862.66191
13 400000 0.093463879 37385.55159
$    1,479,738.91 x 30% probability
Present value = $       443,921.67
For sell at end of first year
Cash flow 2500000
Present value $       625,000.00 (2500000/1.2)
So present value of sell at end of 1 year is higher and woyld be selected
Now come to Total net present value
Common $ (1,933,333.33)
70% probability $    2,071,634.47
30% probability $       625,000.00
Net present value $             763,301 Option C , is NPV of investment

Related Solutions

You are evaluating to make an investment in a small biotech start-up which will require an...
You are evaluating to make an investment in a small biotech start-up which will require an investment of $1.7 million. The start-up is expecting to generate free cash flows of $200,000 during the first year. After one year, the insurance companies will decide if the start-up’s drug will be cover in their plans or not. If they decide to not cover the drug, the company will be able to generate free cash flows of $400,000 during the next 12 years...
You are evaluating to make an investment in a small biotech start-up which will require an...
You are evaluating to make an investment in a small biotech start-up which will require an investment of $1.7 million. The start-up is expecting to generate free cash flows of $200,000 during the first year. After one year, the insurance companies will decide if the start-up’s drug will be cover in their plans or not. If they decide to not cover the drug, the company will be able to generate free cash flows of $400,000 during the next 12 years...
You are evaluating to make an investment in a small biotech start-up which will require an...
You are evaluating to make an investment in a small biotech start-up which will require an investment of $2.1 million. The start-up is expecting to generate free cash flows of $200,000 during the first year. After one year, the insurance companies will decide if the start-up’s drug will be covered in their plans or not. If they decide to not cover the drug, the company will be able to generate free cash flows of $400,000 during the next 12 years...
You are evaluating to make an investment in a small biotechstart-up which will require an...
You are evaluating to make an investment in a small biotech start-up which will require an investment of $1.4 million. The start-up is expecting to generate free cash flows of $200,000 during the first year.After one year, the insurance companies will decide if the start-up’s drug will be cover in their plans or not. If they decide to not cover the drug, the company will be able to generate free cash flows of $400,000 during the next 12 years (the...
Better Health, Inc. is evaluating two investment projects, which require up-front expenditures of $1.0 and 1.2...
Better Health, Inc. is evaluating two investment projects, which require up-front expenditures of $1.0 and 1.2 million, respectively. The projects are expected to produce the following net cash inflows. Year Project A Project B 0 -$1,000,000 -$1,200,000 1 $500,000 $800,000 2 $400,000 $600,000 3 $350,000 $300,000 a. What is each project's IRR? b. What is each project's NPV if the cost of capital is 10 percent? c. Which project is more beneficial to Better Health? Please show your work.
You are evaluating a mining project that will require an initial investment outlay (time 0) of...
You are evaluating a mining project that will require an initial investment outlay (time 0) of $700,000. The project will generate cash flows of $200,000 in Year 1, $300,000 in Year 2, and $400,000 in Year 3. There are no cash flows beyond Year 3. Show work in excel A. What is the NPV of the project at a discount rate of 10%? Explain calculations. B. What is the IRR of the project? Explain calculations. C. Should you invest in...
When evaluating a small start-up company, valuation becomes more art than science. Support your position with...
When evaluating a small start-up company, valuation becomes more art than science. Support your position with evidence or examples.
A consumer products company has identified a potential product which would require $1,800,000 in start-up costs...
A consumer products company has identified a potential product which would require $1,800,000 in start-up costs to launch. If it turns out to be a major success, there will be a $10,000,000 contribution to profit. A minor success would give a profit contribution of $2,000,000, while a failure would have a profit contribution of only $500,000. The company is most worried about this third possibility, since in this case the net profit would be $500,000 minus $1,800,000, i.e. a loss...
You are considering an investment for which you require a 13.5 percent rate of return. The...
You are considering an investment for which you require a 13.5 percent rate of return. The investment costs $58,900 and will produce cash inflows of $25,000 for 3 years. Should you accept this project based on its internal rate of return? Why or why not? A. Yes; because the IRR is 13.13 percent B. Yes; because the IRR is 13.65 percent C. Yes; because the IRR is 13.67 percent D. No; because the IRR is 13.13 percent E. No; because...
Fairfax Pizza is evaluating a project that would require an initial investment in equipment of 200,000...
Fairfax Pizza is evaluating a project that would require an initial investment in equipment of 200,000 dollars and that is expected to last for 6 years. MACRS depreciation would be used where the depreciation rates in years 1, 2, 3, and 4 are 40 percent, 33 percent, 19 percent, and 8 percent, respectively. For each year of the project, Fairfax Pizza expects relevant, incremental annual revenue associated with the project to be 346,000 dollars and relevant, incremental annual costs associated...
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT